RLAY vs. DOW
RLAY (Relay Therapeutics, Inc.) and DOW (Dow Inc.) are both stocks. RLAY operates in Biotechnology (Healthcare), while DOW operates in Chemicals (Basic Materials). Over the past 5 years, RLAY returned -12.73%/yr vs -8.53%/yr for DOW. At a 0.18 correlation, their price movements are largely independent.
Performance
RLAY vs. DOW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RLAY achieves a 104.26% return, which is significantly higher than DOW's 34.61% return.
RLAY
- 1D
- 8.82%
- 1M
- 27.72%
- YTD
- 104.26%
- 6M
- 100.70%
- 1Y
- 441.69%
- 3Y*
- 13.34%
- 5Y*
- -12.73%
- 10Y*
- —
DOW
- 1D
- -2.96%
- 1M
- -13.63%
- YTD
- 34.61%
- 6M
- 34.38%
- 1Y
- 16.72%
- 3Y*
- -10.64%
- 5Y*
- -8.53%
- 10Y*
- —
RLAY vs. DOW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
RLAY Relay Therapeutics, Inc. | 104.26% | 105.34% | -62.58% | -26.31% | -51.35% | -26.11% | 18.74% |
DOW Dow Inc. | 34.61% | -37.38% | -22.79% | 14.71% | -6.65% | 6.81% | 31.69% |
Correlation
The correlation between RLAY and DOW is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2020 | 0.18 |
The correlation between RLAY and DOW shifts across timeframes, from 0.08 (1 year) to 0.20 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
RLAY:
$3.11B
DOW:
$22.21B
RLAY:
-$1.57
DOW:
-$3.86
RLAY:
281.24
DOW:
0.56
RLAY:
4.84
DOW:
1.46
RLAY:
$10.68M
DOW:
$39.33B
RLAY:
$6.33M
DOW:
$2.42B
RLAY:
-$285.68M
DOW:
$840.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RLAY vs. DOW — Risk / Return Rank
RLAY
DOW
RLAY vs. DOW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Relay Therapeutics, Inc. (RLAY) and Dow Inc. (DOW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RLAY | DOW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +6.02 | ||
| Sortino ratioReturn per unit of downside risk | +4.40 | ||
| Omega ratioGain probability vs. loss probability | 1.62 | 1.10 | +0.52 |
| Calmar ratioReturn relative to maximum drawdown | 15.82 | 0.54 | +15.28 |
| Martin ratioReturn relative to average drawdown | 45.15 | 1.00 | +44.14 |
Loading charts...
Drawdowns
RLAY vs. DOW - Drawdown Comparison
The maximum RLAY drawdown since its inception was -96.75%, which is greater than DOW's maximum drawdown of -64.37%. Use the drawdown chart below to compare losses from any high point for RLAY and DOW.
Loading charts...
Drawdown Indicators
| RLAY | DOW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.75% | -64.37% | -32.38% |
Max Drawdown (1Y)Largest decline over 1 year | -28.15% | -31.28% | +3.13% |
Max Drawdown (3Y)Largest decline over 3 years | -84.78% | -62.16% | -22.62% |
Max Drawdown (5Y)Largest decline over 5 years | -94.74% | -64.37% | -30.37% |
Current DrawdownCurrent decline from peak | -71.92% | -44.69% | -27.23% |
Average DrawdownAverage peak-to-trough decline | -69.15% | -22.84% | -46.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.85% | 16.68% | -6.83% |
Volatility
RLAY vs. DOW - Volatility Comparison
Relay Therapeutics, Inc. (RLAY) has a higher volatility of 19.66% compared to Dow Inc. (DOW) at 8.34%. This indicates that RLAY's price experiences larger fluctuations and is considered to be riskier than DOW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RLAY | DOW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.66% | 8.34% | +11.32% |
Volatility (6M)Calculated over the trailing 6-month period | 48.45% | 32.86% | +15.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.13% | 49.26% | +20.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.47% | 33.56% | +44.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.71% | 38.68% | +39.03% |
Dividends
RLAY vs. DOW - Dividend Comparison
RLAY has not paid dividends to shareholders, while DOW's dividend yield for the trailing twelve months is around 4.55%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
DOW Dow Inc. | 4.55% | 8.98% | 6.98% | 5.11% | 5.56% | 4.94% | 5.05% | 3.84% |
RLAY Relay Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RLAY vs. DOW - Financials Comparison
This section allows you to compare key financial metrics between Relay Therapeutics, Inc. and Dow Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RLAY and DOW have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RLAY has higher volatility (19.66%) compared to DOW (8.34%). In terms of maximum drawdown, RLAY dropped -96.75% vs DOW's -64.37%.
RLAY currently has the higher Sharpe Ratio (6.36 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RLAY and DOW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer